These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10338258)

  • 1. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
    Joseph A
    J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycoprotein IIb/IIIa receptor antagonists for improving thrombolytic and interventional therapy in patients with acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Dtsch Med Wochenschr; 2000 Oct; 125(43):1297-300. PubMed ID: 11098229
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
    van den Brand M; Ronner EF
    Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet disaggregation: putting time on your side in acute myocardial infarction.
    Simon DI; Sakuma M
    J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
    [No Abstract]   [Full Text] [Related]  

  • 5. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GPIIB/IIIA blockade after high-risk angioplasty: new perspectives].
    Smiri Z; Lahidheb D; Hajlaoui N; Barakett N; Rahal N; Azzouzi F; Fehri W; Mhenni H; Haouala H
    Tunis Med; 2003; 81 Suppl 8():617-24. PubMed ID: 14608749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycoprotein IIb/IIIa inhibitor wars: an update.
    Berger PB
    J Am Coll Cardiol; 2010 Aug; 56(6):476-8. PubMed ID: 20670757
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
    Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary coronary intervention in acute myocardial infarction.
    Kim CX; Davidson CJ
    Ital Heart J; 2004 Jun; 5 Suppl 6():76S-82S. PubMed ID: 15185919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
    Martinez-Ojeda J; Martinez-Toro J
    Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
    Eccleston D; Topol EJ
    Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tirofiban-induced coronary thrombolysis.
    Jayasundera TG; Feldman DN; Marmur JD
    J Invasive Cardiol; 1999 Mar; 11(3):138-40. PubMed ID: 10745501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.